Victory Capital Management
CYAD

Victory Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Victory Capital Management’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-79,902
Closed -$419K – 2871
2021
Q2 		$419K Sell
79,902
-670,014
-89% -$4M ﹤0.01% 2289
2021
Q1 		$5.23M Sell
749,916
-40,890
-5% -$322K 0.01% 1320
2020
Q4 		$6.17M Sell
790,806
-44,161
-5% -$379K 0.01% 1188
2020
Q3 		$8.33M Buy
834,967
+50,227
+6% +$506K 0.01% 1078
2020
Q2 		$8.52M Sell
784,740
-1,200,976
-60% -$11.7M 0.01% 1052
2020
Q1 		$14.5M Buy
1,985,716
+986,277
+99% +$9.38M 0.01% 982
2019
Q4 		$10.4M Buy
999,439
+45,778
+5% +$460K 0.01% 997
2019
Q3 		$9.62M Buy
953,661
+263,480
+38% +$3.26M 0.01% 997
2019
Q2 		$7.92M Buy
690,181
+17,850
+3% +$340K 0.02% 816
2019
Q1 		$13.7M Buy
672,331
+25,980
+4% +$556K 0.03% 658
2018
Q4 		$11.7M Buy
646,351
+25,189
+4% +$608K 0.03% 682
2018
Q3 		$16.4M Buy
621,162
+17,160
+3% +$503K 0.03% 657
2018
Q2 		$18.7M Buy
604,002
+178,380
+42% +$5.48M 0.04% 617
2018
Q1 		$14.6M Sell
425,622
-18,280
-4% -$760K 0.03% 658
2017
Q4 		$19.5M Buy
443,902
+118,590
+36% +$5.93M 0.04% 587
2017
Q3 		$18.2M Sell
325,312
-47,280
-13% -$2.12M 0.04% 609
2017
Q2 		$15.8M Sell
372,592
-1,901
-0.5% -$75.3K 0.04% 629
2017
Q1 		$9.99M Buy
374,493
+22,600
+6% +$492K 0.02% 691
2016
Q4 		$6.33M Buy
351,893
+580
+0.2% +$11K 0.02% 746
2016
Q3 		$8.29M Buy
+351,313
New +$8.49M 0.02% 690

Other funds holding CYAD

ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Victory Capital Management's CYAD Position: Q3 2021 in Review

Victory Capital Management sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q3 2021, closing a stake of 79,902 shares — an estimated $419K sold.

Victory Capital Management first reported a position in CYAD in Q3 2016 and held it in 20 quarters. The position peaked at $19.5M in Q4 2017. 7 funds tracked by Wall St. Rank hold CYAD as of Q3 2021.

  • Victory Capital Management reported no remaining Celyad Oncology SA American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Victory Capital Management sold 79,902 Celyad Oncology SA American Depositary Shares shares in Q3 2021, an estimated $419K.
  • Victory Capital Management first reported a position in Celyad Oncology SA American Depositary Shares in Q3 2016 and held it in 20 quarters.
  • Victory Capital Management's Celyad Oncology SA American Depositary Shares position peaked at $19.5M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.